San Diego, CA -- (SBWIRE) -- 02/17/2012 -- GTC is pleased to announce three Keynote speakers at the Biomarker Summit 2012, March 15-16 in San Diego, CA. Drs. Carolyn Compton, Steven J. Skates and Khusru Asadullah will present during the Summit plenary session.

Prof. Dr. med. Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer Pharma HealthCare will provide the keynote presentation, “Grants for Targets and Biomarkers - a Novel Open Innovation Initiative in Drug Discovery”.

Dr . Compton, President & CEO, Critical Path Institute, will provide a regulatory update and how it concerns the pharmaceutical industry.

Prior to joining Critical Path Institute, Dr. Compton was the Director of the Office of Biorepositories and Biospecimen Research (OBBR) and the Executive Director of the Cancer Human Biobank (caHUB) project at the National Cancer Institute.

Dr. Skates, Associate Professor of Medicine, Massachusetts General Hospital Cancer Center will present on biomarker research from an academic perspective. Dr. Skates attended the University of Western Australia.

About the Biomarker Summit 2012
Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in diagnostics, oncology and the business of biomarkers. This truly one-of-a-kind, single-stop event has been carefully developed to provide insights into critical issues, discoveries, developments and investments from the most respected names within the biomarker industry. The Summit includes the following tracks:

6th Biomarker Development Conference
4th Oncology Biomarker Conference
Biomarkers & Diagnostic Conference
Biomarkers Partnering & Deal-Making Conference

GTC develops independent events bringing together executive level professionals to acquire the latest industry data while networking and building important business relationships. You may visit GTC at http://www.gtcbio.com.